Research Proposal Template Download

INSTITUTIONAL RESEARCH PROPOSAL AND CONTRACTUAL ENGAGEMENT FRAMEWORK

Document ID: RP-DEF-202X-01
Effective Date: [Effective Date]
Version: 4.2
Governing Jurisdiction: State of [State] / Federal Laws of the United States

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

CRITICAL LEGAL NOTICE: This institutional-grade research proposal and contract template incorporates exhaustive commercial, intellectual property, and risk-allocation provisions. Utilization of this document creates immediate, binding legal obligations upon execution by authorized representatives of the participating entities. Legal counsel and contract operations teams must review all bracketed variables ([...]) to ensure structural alignment with local statutory frameworks, industry-specific compliance mandates (e.g., HIPAA, GDPR, Bayh-Dole Act), and corporate governance policies prior to deployment.

---

2. PARTIES & RECITALS

This Research Proposal and Binding Master Engagement Agreement (the "Agreement") is entered into and made effective as of [Effective Date] (the "Effective Date"), by and between:

SPONSOR / CLIENT:
[Client Full Legal Name], a [State of Incorporation] [Corporation / LLC / Limited Partnership], having its principal place of business at [Principal Address] (hereinafter referred to as the "Client").

RESEARCH INSTITUTION / PROVIDER:
[Company Full Legal Name], a [State of Incorporation] [Corporation / LLC / Research Entity], having its principal place of business at [Principal Address] (hereinafter referred to as the "Researcher").

RECITALS

WHEREAS, the Client desires to engage the Researcher to perform specialized academic, scientific, or commercial research services as outlined herein;
WHEREAS, the Researcher possesses the requisite expertise, personnel, infrastructure, and academic credentials to execute the proposed research program; and
WHEREAS, the Parties intend to establish the legal, financial, and operational terms governing the execution of the Research Project and the protection of respective intellectual properties and confidential disclosures.

NOW, THEREFORE, in consideration of the mutual covenants, promises, and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

SECTION 1: SCOPE OF SERVICES & RESEARCH ENGAGEMENT

1.1 Research Project Commission. The Client hereby engages the Researcher, and the Researcher accepts such engagement, to perform the research services described in the Statement of Work (SOW) attached hereto as Exhibit A (the "Research Project"). The Researcher shall perform all work with a high degree of professional and scientific competence, adhering strictly to the timelines, milestones, and deliverables specified in Exhibit A.

1.2 Modifications to Scope. Any material modification, expansion, or reduction of the scope of the Research Project shall be set forth in a written change order signed by the authorized representatives of both Parties (the "Change Order"). The Researcher shall not be obligated to perform any work outside the defined scope until a mutually agreed-upon Change Order detailing adjustments to compensation and delivery timelines has been fully executed.

1.3 Academic Freedom and Publication. The Researcher maintains the right to publish academic and scientific findings derived from the Research Project, subject to the review provisions set forth in Section 5 (Confidentiality). The Client acknowledges that the primary objective of academic research includes the dissemination of knowledge and public education.

SECTION 2: COMPENSATION & PAYMENT TERMS

2.1 Total Consideration. In consideration for the full and faithful performance of the research services, the Client shall pay to the Researcher the total sum of [Amount in USD] USD (the "Contract Price"), payable in accordance with the milestone payment schedule set forth in Exhibit B.

2.2 Invoicing Schedule. The Researcher shall issue invoices to the Client upon the completion of specific milestones or on a [Monthly / Quarterly] basis, as designated in Exhibit B. All invoices shall be delivered electronically to the Client’s designated billing contact at [Client Billing Email Address].

2.3 Payment Terms. Net thirty (30) days from the formal date of receipt of an undisputed invoice. Payments shall be remitted via wire transfer or electronic funds transfer (EFT) to the banking coordinates provided by the Researcher in Exhibit B.

2.4 Late Interest and Remedies. Any undisputed amounts not paid when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated from the date such payment was due until the date paid in full. If the Client fails to pay any undisputed invoice within fifteen (15) days of receiving written notice of delinquency, the Researcher reserves the right to suspend performance under this Agreement until all delinquent balances and accrued interest are received in full.

2.5 Taxes. The Contract Price is exclusive of all applicable federal, state, and local sales, use, value-added, or excise taxes. The Client shall be solely responsible for the payment of all such taxes, excluding taxes levied upon the net income of the Researcher.

SECTION 3: TERM & TERMINATION

3.1 Term of Agreement. This Agreement shall commence on the Effective Date and shall continue in full force and effect until the completion of the Research Project and delivery of final reports, or until terminated earlier in accordance with the provisions of this Section 3 (the "Term").

3.2 Termination for Convenience. The Client may terminate this Agreement, in whole or in part, for any reason or no reason, upon providing thirty (30) days prior written notice to the Researcher. Upon receipt of such notice, the Researcher shall immediately cease all non-essential work and take all reasonable steps to mitigate costs incurred.

3.3 Termination for Cause (Breach). Either Party may terminate this Agreement immediately upon written notice if the other Party materially breaches any of its representations, warranties, or material obligations hereunder, and fails to cure such material breach within thirty (30) days following receipt of written notice detailing the specific nature of the breach.

3.4 Effect of Termination. Upon termination of this Agreement for any reason:

• (a) The Client shall promptly pay the Researcher for all services satisfactorily rendered, milestones achieved, and non-cancelable third-party commitments incurred up to the effective date of termination.
• (b) Each Party shall promptly return or destroy (and certify destruction of) all Confidential Information belonging to the other Party in accordance with Section 5.
• (c) Sections 4 (Intellectual Property), 5 (Confidentiality), 7 (Limitation of Liability), and 8 (Dispute Resolution) shall survive the expiration or termination of this Agreement indefinitely or for the maximum period permitted by law.

SECTION 4: INTELLECTUAL PROPERTY OWNERSHIP

4.1 Background Intellectual Property. Each Party retains all right, title, and interest in and to its pre-existing intellectual property, methodologies, trade secrets, software, and know-how developed independently of this Agreement ("Background IP"). No license or right to Background IP is granted to the other Party except as expressly set forth herein.

4.2 Foreground Intellectual Property (Inventions & Data). All intellectual property, inventions, discoveries, patents, copyrights, trade secrets, and research data conceived, reduced to practice, or authored exclusively by the Researcher in the direct performance of the Research Project (collectively, "Foreground IP") shall be owned exclusively by the Researcher, subject to the license grants set forth in this Section 4.

4.3 Commercialization Rights & Options. The Researcher hereby grants to the Client an exclusive, [worldwide / territory-specific], time-limited option to negotiate a commercial license to the Researcher's right, title, and interest in the Foreground IP upon commercially reasonable terms. The Client must exercise this option in writing within sixty (60) days following the formal disclosure of the Foreground IP by the Researcher. If the Client fails to exercise this option within the stipulated timeframe, the Researcher shall retain unencumbered rights to commercialize or license the Foreground IP to third parties.

SECTION 5: MUTUAL CONFIDENTIALITY & NON-DISCLOSURE

5.1 Definition of Confidential Information. "Confidential Information" means all non-public, proprietary, or confidential data, documents, technical specifications, research notes, trade secrets, financial information, and business strategies disclosed by one Party (the "Disclosing Party") to the other Party (the "Receiving Party"), whether orally or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure.

5.2 Obligations of Confidentiality. The Receiving Party shall:

• (a) Maintain the strict confidentiality of all Disclosing Party Confidential Information using at least the same degree of care it uses to protect its own proprietary information, but in no event less than a reasonable standard of care;
• (b) Restrict disclosure of Confidential Information solely to its employees, directors, legal counsel, and academic contractors who have a strict need to know such information for the execution of the Research Project and who are bound by written confidentiality obligations at least as restrictive as those contained herein; and
• (c) Not use the Confidential Information for any purpose outside the scope of this Agreement.

5.3 Exclusions. Confidential Information shall not include information that:

• (a) Is or becomes generally known to the public through no breach of this Agreement by the Receiving Party;
• (b) Was already in the possession of the Receiving Party prior to disclosure without an obligation of confidentiality;
• (c) Is rightfully received from a third party without restriction and without breach of any confidentiality obligation; or
• (d) Is independently developed by the Receiving Party without reference to or reliance upon the Disclosing Party’s Confidential Information.

5.4 Compelled Disclosure. If the Receiving Party is legally compelled by a court, regulatory agency, or government subpoena to disclose any Confidential Information, the Receiving Party shall, to the extent legally permissible, provide prompt written notice to the Disclosing Party so that the Disclosing Party may seek a protective order or other appropriate remedy.

SECTION 6: REPRESENTATIONS & WARRANTIES

6.1 Mutual Representations. Each Party represents and warrants that:

• (a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation;
• (b) It has all requisite corporate power and authority to execute, deliver, and perform its obligations under this Agreement; and
• (c) The execution and performance of this Agreement do not violate any applicable law, rule, regulation, or contractual commitment to which it is bound.

6.2 Researcher Warranties. The Researcher warrants that the research services will be performed in a professional, workmanlike manner, in accordance with generally accepted academic and scientific standards.

6.3 Disclaimer of Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 6, THE RESEARCHER MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. THE RESEARCH PROJECT IS EXPERIMENTAL IN NATURE, AND THE RESEARCHER DOES NOT GUARANTEE THAT ANY SPECIFIC COMMERCIAL OR SCIENTIFIC OUTCOME WILL BE ACHIEVED.

SECTION 7: LIMITATION OF LIABILITY & INDEMNIFICATION

7.1 Limitation of Liability. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES (INCLUDING LOSS OF PROFITS, LOSS OF REVENUE, LOSS OF DATA, OR LOSS OF BUSINESS OPPORTUNITY), ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE THEORY OF LIABILITY (CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR OTHERWISE), AND EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

7.2 Aggregate Liability Cap. The total aggregate liability of either Party arising out of or relating to this Agreement, under any and all legal theories, shall be strictly limited to the total Contract Price actually paid by the Client to the Researcher under this Agreement in the twelve (12) months preceding the event giving rise to liability.

7.3 Client Indemnification. The Client shall defend, indemnify, and hold harmless the Researcher, its trustees, officers, employees, agents, and academic contractors from and against any and all third-party claims, liabilities, losses, damages, judgments, and reasonable expenses (including attorney’s fees) arising out of or resulting from:

• (a) The commercialization, distribution, or clinical use of products developed from the Foreground IP by the Client or its affiliates;
• (b) Any material breach of this Agreement by the Client; or
• (c) The gross negligence or willful misconduct of the Client, its agents, or employees.

SECTION 8: DISPUTE RESOLUTION & ARBITRATION

8.1 Good Faith Negotiation. In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the designated senior executives of both Parties shall attempt in good faith to resolve such dispute through direct business negotiations for a period of thirty (30) days from the date of written notice of the dispute.

8.2 Binding Arbitration. If the dispute remains unresolved following the thirty (30) day negotiation period, the controversy shall be settled by binding arbitration administered by the American Arbitration Association (AAA) in accordance with its Commercial Arbitration Rules. The place of arbitration shall be [City, State]. The arbitration shall be conducted by a single neutral arbitrator appointed in accordance with AAA rules. The award rendered by the arbitrator shall be final and binding, and judgment upon the award may be entered in any court having competent jurisdiction.

SECTION 9: GOVERNING LAW & JURISDICTION

9.1 Governing Law. This Agreement, and all claims or causes of action (whether in contract, tort, or statute) that may be based upon, arise out of, or relate to this Agreement, shall be governed by, enforced under, and construed in accordance with the internal laws of the State of [State], without regard to its conflict of laws principles.

SECTION 10: MISCELLANEOUS PROVISIONS

10.1 Severability. If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions of this Agreement shall remain in full force and effect.

10.2 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed signature page by electronic mail (PDF) or digital signature platform (e.g., DocuSign) shall be fully effective as physical delivery of an original executed copy.

10.3 Entire Agreement. This Agreement, including all attached Exhibits, SOWs, and Change Orders, constitutes the final, complete, and exclusive expression of the agreement between the Parties with respect to the subject matter hereof, and supersedes all prior and contemporaneous negotiations, discussions, understandings, and agreements, whether oral or written.

---

4. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the Parties hereto have caused this Institutional Research Proposal and Binding Master Engagement Agreement to be executed by their respective duly authorized officers as of the Effective Date.

FOR [COMPANY FULL LEGAL NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Legal Name]
Date: [Date]

FOR [CLIENT FULL LEGAL NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Client Full Legal Name]
Date: [Date]

---

5. STEP-BY-STEP EXECUTION & FILING GUIDE

1. Document Customization: Download or copy this template into a word processor (Microsoft Word or Google Docs). Locate all bracketed placeholders (e.g., [Company Full Legal Name], [Effective Date], [Amount in USD]) and replace them with verified, accurate corporate and financial data.
2. Exhibit Assembly: Draft and attach the comprehensive research scope in Exhibit A (Statement of Work) and the detailed milestone payment schedules in Exhibit B.
3. Legal Review: Submit the populated draft to internal or external legal counsel to confirm that Governing Jurisdiction provisions align with local state statutes and corporate risk tolerance thresholds.
4. Signatory Verification: Verify that the individuals executing the signature blocks hold active corporate authority (e.g., CEO, President, Managing Director, or authorized delegate) to bind their respective legal entities.
5. Execution via Digital Platforms: Route the finalized contract through an institutional digital signature solution (such as DocuSign or Adobe Sign) to ensure cryptographic audit trails and tamper-evident execution.
6. Record Retention: Archive the fully executed PDF contract, along with corresponding digital signature audit certificates, in the corporate contract repository for the duration of the Term plus the applicable statute of limitations (minimum 7 years).